Influenza
Conditions
Interventions
Sponsors
Chiba University Hospital
Shionogi Co. Ltd. The National Institute of Infectious Diseases
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Persons who have completed junior high school or are over 16 years old and under 80 years old at the time of obtaining consent 2) Patients with a positive influenza rapid diagnostic test (RAT) performed using a nasal cavity or nasopharyngeal swab on the day of consent acquisition 3) Subjects who have received sufficient explanation and informed written consent of their own free will to participate in this study.
Exclusion criteria
Exclusion criteria: Persons who fall under any of the following 1)Patients who have received anti-influenza virus drugs within the past 7 days 2) Other persons deemed unsuitable by the research director
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Threshold value based on logistic regression and ROC analysis using specific antibody titer against influenza virus antigen and success/failure of virus isolation test | — |
Secondary
| Measure | Time frame |
|---|---|
| Sensitivity, specificity, and ROC-AUC were determined by logistic regression and ROC analysis using specific antibody titers against influenza virus antigens and the success or failure of virus isolation tests. | — |
Countries
Japan
Contacts
Public ContactMorio Nagira
Chiba University Hospital Department of Human Mucosal Vaccinology
Outcome results
None listed